Felice C. Adler‐Shohet

663 total citations
30 papers, 410 citations indexed

About

Felice C. Adler‐Shohet is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Felice C. Adler‐Shohet has authored 30 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 15 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Felice C. Adler‐Shohet's work include Tuberculosis Research and Epidemiology (6 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Pneumonia and Respiratory Infections (5 papers). Felice C. Adler‐Shohet is often cited by papers focused on Tuberculosis Research and Epidemiology (6 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Pneumonia and Respiratory Infections (5 papers). Felice C. Adler‐Shohet collaborates with scholars based in United States, Vietnam and Australia. Felice C. Adler‐Shohet's co-authors include Jay M. Lieberman, Jennifer Lê, Michele Cheung, Jasjit Singh, Georg Hempel, Gudrun Würthwein, Andreas H. Groll, Thomas J. Walsh, MARYANN HILL and Negar Ashouri and has published in prestigious journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and The Journal of Pediatrics.

In The Last Decade

Felice C. Adler‐Shohet

27 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Felice C. Adler‐Shohet United States 13 214 192 103 74 74 30 410
Maria Cusato Italy 13 297 1.4× 333 1.7× 212 2.1× 96 1.3× 51 0.7× 28 747
Eda Kepenekli Türkiye 14 168 0.8× 186 1.0× 46 0.4× 36 0.5× 66 0.9× 61 485
Haluk Güri̇z Türkiye 13 131 0.6× 302 1.6× 44 0.4× 92 1.2× 57 0.8× 36 487
Hayden T. Schwenk United States 10 129 0.6× 173 0.9× 50 0.5× 40 0.5× 33 0.4× 46 344
Maia De Luca Italy 10 75 0.4× 201 1.0× 44 0.4× 52 0.7× 100 1.4× 39 361
Ayşe Karaaslan Türkiye 13 128 0.6× 157 0.8× 30 0.3× 30 0.4× 55 0.7× 50 400
H.A. Verbrugh Netherlands 10 165 0.8× 183 1.0× 95 0.9× 30 0.4× 33 0.4× 20 458
Antônia Teresinha Tresoldi Brazil 13 165 0.8× 219 1.1× 25 0.2× 34 0.5× 108 1.5× 36 487
W Huck United States 10 71 0.3× 252 1.3× 68 0.7× 59 0.8× 75 1.0× 13 372
Yu. V. Lobzin Russia 10 194 0.9× 237 1.2× 23 0.2× 27 0.4× 41 0.6× 99 593

Countries citing papers authored by Felice C. Adler‐Shohet

Since Specialization
Citations

This map shows the geographic impact of Felice C. Adler‐Shohet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felice C. Adler‐Shohet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felice C. Adler‐Shohet more than expected).

Fields of papers citing papers by Felice C. Adler‐Shohet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Felice C. Adler‐Shohet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felice C. Adler‐Shohet. The network helps show where Felice C. Adler‐Shohet may publish in the future.

Co-authorship network of co-authors of Felice C. Adler‐Shohet

This figure shows the co-authorship network connecting the top 25 collaborators of Felice C. Adler‐Shohet. A scholar is included among the top collaborators of Felice C. Adler‐Shohet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felice C. Adler‐Shohet. Felice C. Adler‐Shohet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nieves, Delma, Jasjit Singh, Negar Ashouri, et al.. (2025). Remdesivir Use in Pediatric Patients with Acute SARS-CoV-2 Infection Is Safe and Well Tolerated. Children. 12(3). 331–331.
2.
Gaensbauer, James, et al.. (2024). Multidrug-resistant tuberculosis in children: A practical update on epidemiology, diagnosis, treatment and prevention. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 36. 100449–100449.
3.
Adler‐Shohet, Felice C., et al.. (2024). Neurological and neuroimaging implications of COVID-19 in the pediatric population.. 10(1). 5–19.
4.
Ericson, Jessica E., Daniel K. Benjamin, Felix Boakye‐Agyeman, et al.. (2022). Exposure-safety relationship for acyclovir in the treatment of neonatal herpes simplex virus disease. Early Human Development. 170. 105616–105616. 2 indexed citations
5.
Jhaveri, Ravi, Felice C. Adler‐Shohet, Christopher C. Blyth, et al.. (2021). Weighing the Risks of Perimyocarditis With the Benefits of SARS-CoV-2 mRNA Vaccination in Adolescents. Journal of the Pediatric Infectious Diseases Society. 10(10). 937–939. 5 indexed citations
6.
Sauberan, Jason, et al.. (2021). Implementation of Vancomycin Therapeutic Monitoring Guidelines: Focus on Bayesian Estimation Tools in Neonatal and Pediatric Patients. Therapeutic Drug Monitoring. 44(2). 241–252. 15 indexed citations
7.
Edwards, Kathryn M., Daniel Olson, Felice C. Adler‐Shohet, et al.. (2020). Pre-Coronavirus Disease 2019 Telehealth Practices Among Pediatric Infectious Diseases Specialists in the United States. Journal of the Pediatric Infectious Diseases Society. 10(4). 485–491. 5 indexed citations
8.
Adler‐Shohet, Felice C., et al.. (2019). Safety and Tolerability of Clofazimine in a Cohort of Children With Odontogenic Mycobacterium abscessus Infection. Journal of the Pediatric Infectious Diseases Society. 9(4). 483–485. 9 indexed citations
9.
10.
González, Daniel, Laura P. James, Amira Al‐Uzri, et al.. (2018). Population Pharmacokinetics and Safety of Solithromycin following Intravenous and Oral Administration in Infants, Children, and Adolescents. Antimicrobial Agents and Chemotherapy. 62(8). 4 indexed citations
11.
Adler‐Shohet, Felice C., et al.. (2017). Clofazimine for Treatment of Mycobacterium abscessus Infections in Children. Open Forum Infectious Diseases. 4(suppl_1). S675–S675. 2 indexed citations
12.
Lê, Jennifer, Quang Dam, T.A. Tran, et al.. (2017). Epidemiology and hospital readmission associated with complications ofStaphylococcus aureusbacteremia in pediatrics over a 25-year period. Epidemiology and Infection. 145(12). 2631–2639. 26 indexed citations
13.
Adler‐Shohet, Felice C., et al.. (2014). Management of Latent Tuberculosis Infection in Child Contacts of Multidrug-Resistant Tuberculosis. The Pediatric Infectious Disease Journal. 33(6). 664–666. 27 indexed citations
14.
Lê, Jennifer, et al.. (2013). Time to Initiation of Antifungal Therapy for Neonatal Candidiasis. Antimicrobial Agents and Chemotherapy. 57(6). 2550–2555. 4 indexed citations
15.
16.
Nieves, Delma, et al.. (2011). Clinical and Laboratory Features of Pertussis in Infants at the Onset of a California Epidemic. The Journal of Pediatrics. 159(6). 1044–1046. 22 indexed citations
17.
Singh, Jasjit, et al.. (2010). A CLUSTER OF PEDIATRIC ENDEMIC TYPHUS CASES IN ORANGE COUNTY, CALIFORNIA. The Pediatric Infectious Disease Journal. 30(2). 163–165. 10 indexed citations
18.
Lê, Jennifer, et al.. (2009). Nephrotoxicity Associated With Amphotericin B Deoxycholate in Neonates. The Pediatric Infectious Disease Journal. 28(12). 1061–1063. 41 indexed citations
19.
Adler‐Shohet, Felice C., Michele Cheung, MARYANN HILL, & Jay M. Lieberman. (2003). Aseptic meningitis in infants younger than six months of age hospitalized with urinary tract infections. The Pediatric Infectious Disease Journal. 22(12). 1039–1042. 35 indexed citations
20.
Adler‐Shohet, Felice C., Pamela S. Palmer, George Reed, & Kathryn M. Edwards. (1996). PREVALENCE OF HELICOBACTER PYLORI ANTIBODIES IN NORMAL CHILDREN. The Pediatric Infectious Disease Journal. 15(2). 172–174. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Cusato Breakdown of academic impact, for papers by Eda Kepenekli Breakdown of academic impact, for papers by Haluk Güri̇z Breakdown of academic impact, for papers by Hayden T. Schwenk Breakdown of academic impact, for papers by Maia De Luca Breakdown of academic impact, for papers by Ayşe Karaaslan Breakdown of academic impact, for papers by H.A. Verbrugh Breakdown of academic impact, for papers by Antônia Teresinha Tresoldi Breakdown of academic impact, for papers by W Huck Breakdown of academic impact, for papers by Yu. V. Lobzin
Rankless by CCL
2026